首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1739461

2026 年至 2032 年切片穿刺针市场（按产品类型、应用、程序、最终用户和地区划分）

Biopsy Needles Market by Product Type, Application, Procedure, End-User & Region for 2026-2032

出版日期: 2025年05月08日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2026-2032年切片穿刺针市场评估

随着癌症发病率的上升以及人们对早期检测意识的增强，切片穿刺针市场正在迅速扩张。这些针头用于采集组织样本进行诊断测试。切片检查技术的进步、人口老化加剧以及政府癌症宣传倡议的加强是推动市场发展的主要因素。预计这些因素将推动市场规模在2024年突破103.6亿美元，到2032年达到178.3亿美元。

由于先进的医疗基础设施和较高的癌症发病率，北美占据了最大的市场占有率。市场的主要企业包括Becton Dickinson & Company、Hologic, Inc.和Argon Medical Devices, Inc.。随着对微创手术的需求不断增长，该行业预计将继续增长。切片穿刺针的需求不断增长，使得市场在2026年至2032年间的复合年增长率达到7.02%。

切片穿刺针市场定义/概述

切片穿刺针是一种用于从体内取出组织样本进行诊断的专用医疗器材。切片穿刺针针有很多不同的类型，包括芯针、细针和真空辅助针，每种类型都适用于特定的组织类型和诊断需求，尤其是癌症检测。

切片穿刺针用于获取组织样本进行诊断检测，有助于诊断和分析包括癌症在内的疾病。切片穿刺针提供了一种从身体各部位获取细胞的微创方法，从而为诊断和治疗计划提供重要资讯。

随着微创技术的发展、癌症诊断技术的进步以及人们对早期疾病检测意识的提升，切片穿刺针在未来可能会变得更加普及。活检针技术的改进，例如精准度的提升和患者不适感的减轻，可能会加速其在临床实践中的应用。

人口老化加剧是否会推动切片穿刺针市场的成长？

人口老化预计将大幅推动切片穿刺针市场的发展。根据美国人口普查局的数据，到2030年，所有婴儿潮世代都将年满65岁或以上，老年人口总数将达到730亿人。这群人更有可能需要针刺活检等诊断程序。

根据美国国家癌症美国的数据，约有39.5%的男性和女性在其一生中的某个阶段会被诊断出患有癌症，诊断年龄中位数为66岁。美国疾病管制与预防中心报告称，2018年新增癌症病例1,708,921例，癌症已成为65岁及以上人口的第二大死因。到2050年，美国65岁及以上人口预计将达到885亿，这将进一步增加对切片穿刺针的需求。

切片检查手术的高成本是否会阻碍切片穿刺针市场的发展？

切片检查程序的高成本可能会限制切片穿刺针市场的成长。切片检查程序（包括先进的成像技术和专用针头）的成本对于某些个人和医疗保健系统来说可能过于昂贵，尤其是在资源匮乏的地区。

此外，高昂的费用可能会阻碍患者接受诊断性治疗，尤其是在他们没有完全医疗保险的情况下。这种负担能力障碍可能会限制重要的诊断检测，导致诊断和治疗延误。虽然技术发展和癌症等疾病的流行将推动切片穿刺针的需求，但治疗成本可能会限制市场发展。降低价格和增加医疗保健可近性的措施可能有助于缓解这些问题并扩大市场。

The Biopsy Needles Market is expanding rapidly due to the rising prevalence of cancer and increasing awareness of early detection. These needles are required for collecting tissue samples for diagnostic testing. Technological advancements in biopsy techniques, a growing aging population and increasing government cancer awareness initiatives are among the key market drivers. This is likely to enable the market size surpass USD 10.36 Billion valued in 2024 to reach a valuation of around USD 17.83 Billion by 2032.

North America possesses the largest market share due to advanced healthcare infrastructure and high cancer incidence rates. Key players in the market include companies like Becton, Dickinson and Company, Hologic, Inc. and Argon Medical Devices. The industry is likely to continue rising as demand for minimally invasive procedures increases. The rising demand for Biopsy Needles is enabling the market grow at a CAGR of 7.02% from 2026 to 2032.

Biopsy Needles Market: Definition/ Overview

Biopsy needles are specialist medical devices that collect tissue samples from the body for diagnostic purposes. They come in a variety of styles, including core, fine and vacuum-assisted needles, each suited for a specific tissue type and diagnostic necessity, particularly in cancer detection.

Biopsy needles are used to collect tissue samples for diagnostic testing, which aids in the diagnosis and analysis of diseases, including cancer. They provide a minimally invasive way for collecting cells from diverse bodily areas, thereby providing critical information for diagnosis and treatment planning.

Biopsy needles will most likely be used more in the future as minimally invasive techniques evolve, cancer diagnoses improve and awareness of early illness detection grows. Improved needle technologies, such as increasing precision and less patient discomfort, will accelerate their use in medical practices.

Will Growing Aging Population to Boost the Biopsy Needles Market Growth?

The growing aging population is expected to significantly boost the biopsy needle market. According to the US Census Bureau, by 2030, all baby boomers will be over the age of 65, bringing the total number of older people to 73 Billion. This demographic is more likely to require diagnostic procedures like needle biopsy.

According to the National Cancer Institute, approximately 39.5% of men and women will be diagnosed with cancer at some point during their lifetimes, with the median age for diagnosis being 66 years. The CDC reported 1,708,921 new cancer cases in 2018, with cancer being the second leading cause of death among those aged 65 and older. By 2050, the number of Americans aged 65 and older is predicted to reach 88.5 Billion, further raising need for biopsy needles.

Will High Cost of Biopsy Operations Hamper the Biopsy Needles Market?

The high cost of biopsy surgeries may limit the growth of the biopsy needles market. The costs of biopsy treatments, such as advanced imaging techniques and specialized needles, might be too expensive for some individuals and healthcare systems, especially in areas with low healthcare financing.

Furthermore, high costs may discourage patients from pursuing diagnostic treatments, particularly in the absence of full insurance coverage. This price barrier can limit access to important diagnostic testing, potentially resulting in delayed diagnosis and treatment. While technical developments and the rising prevalence of diseases such as cancer fuel demand for biopsy needles, the market's expansion may be limited by the cost of treatments. Efforts to cut prices and enhance healthcare access could help to mitigate these issues and expand the market.

Category-Wise Acumens

Will Increasing Need for Early and Accurate Diagnosis Drive the Application Segment?

The growing demand for early and precise diagnosis is a major driver in the biopsy needles application area. Early diagnosis of diseases such as cancer is critical to improve treatment outcomes and survival rates. Biopsy needles are essential for collecting tissue samples for definitive diagnosis, as they aid in determining the presence and stage of illnesses. As healthcare systems prioritize preventive care and precision medicine, the demand for improved diagnostic instruments, such as biopsy needles, increases.

Furthermore, technical advances in biopsy needle design and imaging techniques improve the accuracy and safety of treatments. The rising emphasis on early diagnosis and individualized treatment strategies is projected to drive biopsy needle utilization and market growth.

Will Increasing Demand for Greater Accuracy and Precision in Locating and Sampling Tissues Drive the Procedure Segment?

The growing demand for improved accuracy and precision in locating and sampling tissues is a major driver in the image-guided biopsy procedures market. Image-guided techniques, which use technologies such as ultrasound, CT, or MRI, improve the precision of biopsies by allowing for real-time viewing of target locations. This lowers the likelihood of sampling errors, complications and the need for repeat treatments, ultimately increasing diagnostic accuracy and patient outcomes.

As healthcare professionals and consumers seek more reliable and minimally invasive diagnostic approaches, image-guided biopsies are becoming increasingly popular. This tendency is bolstered by technology advances in imaging and needle design, which make these treatments safer and more efficient. As a result, the demand for image-guided biopsy treatments is likely to rise, boosting the total market for biopsy needles.

Country/Region-wise Acumens

Will High Prevalence of Cancer Drive the Market in North America?

The rising rate of cancer is driving the demand for biopsy needles in North America. With cancer being one of the main causes of mortality in the region, there is a significant emphasis on early identification and correct diagnosis, both of which are critical for effective treatment and improved patient outcomes. North America's well-established healthcare system, combined with extensive access to improved diagnostic tools, makes biopsy needles useful for identifying many malignancies.

Furthermore, a growing understanding of the necessity of regular screenings and early detection contributes to the rising demand for biopsy treatments. Supportive government initiatives and healthcare policies also contribute to industry growth. Consequently, the high cancer prevalence is a crucial element driving the rise of the biopsy needles market in North America.

Will Increasing Healthcare Investments Drive the Market in Asia Pacific Region?

Increasing healthcare investments are a key driver of the Asia-Pacific biopsy needles market. As countries in this region improve their healthcare infrastructure, there is a greater emphasis on strengthening diagnostic skills and increasing access to innovative medical technologies. Governments and business sectors are investing in updating hospitals, clinics and diagnostic centers, increasing the availability of biopsy procedures. This investment also helps healthcare professionals' training in the use of sophisticated diagnostic technologies, which will help to drive market growth.

Furthermore, greater knowledge about early illness detection, combined with an aging population and an increasing prevalence of cancer, drives up demand for biopsy needles. As healthcare systems in Asia-Pacific improve, the market for biopsy needles is likely to rise, driven by these significant investments and the growing emphasis on quality healthcare.

Competitive Landscape

The biopsy needles market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the biopsy needles market include:

Becton

Medtronic plc

Boston Scientific Corporation

FUJIFILM Holdings Corporation

Dickinson & Company (BD)

Becton

Cardinal Health

Hologic, Inc.

Olympus Corporation

Argon Medical Devices, Inc.

Devicor Medical Products, Inc.

Braun Melsungen AG

Cook Group Incorporated

Latest Developments

In November 2022, Cambridge Enterprise released the Cambridge Prostate Biopsy Device (CamPROBE) to minimize infection risk during transrectal biopsies. This unique device includes an integrated needle for localized anesthetic delivery.

In August 2022, Mammotome launched its Mammotome DualCore biopsy system, making its debut in the dual-stage core biopsy equipment market. The device's lightweight, ergonomic and clever design minimizes needle movements and vibrations while improving the entire patient experience.

1. Introduction

Market Definition
Market Segmentation
Research Methodology

2. Executive Summary

Key Findings
Market Overview
Market Highlights

3. Market Overview

Market Size and Growth Potential
Market Trends
Market Drivers
Market Restraints
Market Opportunities
Porter's Five Forces Analysis

4. Biopsy Needles Market, By Product Type

Biopsy Needles
Aspiration Needles

5. Biopsy Needles Market, By Application

Tumor/Cancer Applications
Wound Applications

6. Biopsy Needles Market, By Procedure

Image-guided Procedures
Non-image-guided Procedures

Biopsy Needles Market, By End-User

Hospitals & Surgical Centers
Diagnostic Clinics & Pathology Laboratories
Ambulatory Care Centers
Research & Academic Institutes

7. Regional Analysis

North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Asia-Pacific
China
Japan
India
Australia
Latin America
Brazil
Argentina
Chile
Middle East and Africa
South Africa
Saudi Arabia
UAE

8. Market Dynamics

Market Drivers
Market Restraints
Market Opportunities
Impact of COVID-19 on the Market

9. Competitive Landscape

Key Players
Market Share Analysis

10. Company Profiles

Becton
Medtronic plc
Boston Scientific Corporation
FUJIFILM Holdings Corporation
Dickinson & Company (BD)
Becton
Cardinal Health
Hologic, Inc.
Olympus Corporation
Argon Medical Devices, Inc.
Devicor Medical Products, Inc.
Braun Melsungen AG
Cook Group Incorporated

11. Market Outlook and Opportunities

Emerging Technologies
Future Market Trends
Investment Opportunities

12. Appendix

List of Abbreviations
Sources and References

02-2729-4219

+886-2-2729-4219

License/价格

2026 年至 2032 年切片穿刺针市场（按产品类型、应用、程序、最终用户和地区划分）

Biopsy Needles Market by Product Type, Application, Procedure, End-User & Region for 2026-2032

2026-2032年切片穿刺针市场评估

人口老化加剧是否会推动切片穿刺针市场的成长？

切片检查手术的高成本是否会阻碍切片穿刺针市场的发展？

目录

第一章 引言

第二章执行摘要

第三章市场概述

第四章切片穿刺针市场（按产品类型）

第五章切片穿刺针市场（按应用）

第六章切片穿刺针市场（按程序）

切片穿刺针市场（按最终用户划分）

第七章区域分析

第八章市场动态

第九章 竞争态势

第十章 公司简介

第十一章 市场展望与机会

第十二章 附录

Biopsy Needles Market Valuation - 2026-2032